Research Analysts Issue Forecasts for Fortrea Q1 Earnings

Fortrea Holdings Inc. (NASDAQ:FTRE) – Stock analysts at William Blair cut their Q1 2025 earnings estimates for Fortrea in a research note issued to investors on Monday, March 3rd. William Blair analyst M. Smock now anticipates that the company will post earnings of ($0.24) per share for the quarter, down from their prior estimate of $0.28. William Blair has a “Market Perform” rating on the stock. The consensus estimate for Fortrea’s current full-year earnings is $0.51 per share. William Blair also issued estimates for Fortrea’s Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at $0.23 EPS, FY2025 earnings at $0.37 EPS, Q1 2026 earnings at ($0.12) EPS, Q2 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.40 EPS and FY2026 earnings at $0.67 EPS.

Fortrea (NASDAQ:FTRE) last issued its quarterly earnings data on Monday, March 3rd. The company reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.18). The business had revenue of $697.00 million during the quarter, compared to analyst estimates of $703.22 million. Fortrea had a negative net margin of 10.99% and a positive return on equity of 2.00%. During the same period in the previous year, the company posted $0.19 earnings per share.

A number of other research firms have also recently commented on FTRE. Barclays dropped their price objective on Fortrea from $25.00 to $12.00 and set an “equal weight” rating for the company in a research report on Tuesday. Baird R W lowered Fortrea from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 6th. Evercore ISI dropped their target price on Fortrea from $20.00 to $15.00 and set an “in-line” rating for the company in a research note on Tuesday. Citigroup lowered Fortrea from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $30.00 to $23.00 in a research note on Wednesday, December 11th. Finally, Robert W. Baird lowered shares of Fortrea from an “outperform” rating to a “neutral” rating and cut their price objective for the stock from $28.00 to $25.00 in a report on Friday, December 6th. One analyst has rated the stock with a sell rating and eleven have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $20.30.

Fortrea Price Performance

Shares of NASDAQ:FTRE opened at $10.89 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.18 and a current ratio of 1.18. The business’s fifty day moving average price is $16.66 and its two-hundred day moving average price is $19.01. The stock has a market cap of $976.83 million, a PE ratio of -3.18, a price-to-earnings-growth ratio of 1.78 and a beta of 1.34. Fortrea has a one year low of $9.55 and a one year high of $41.02.

Insiders Place Their Bets

In other Fortrea news, CEO Thomas Pike sold 11,268 shares of the stock in a transaction on Monday, January 13th. The shares were sold at an average price of $18.04, for a total transaction of $203,274.72. Following the transaction, the chief executive officer now directly owns 159,868 shares in the company, valued at $2,884,018.72. This represents a 6.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders have sold 12,386 shares of company stock worth $219,751 in the last three months. 0.12% of the stock is owned by insiders.

Institutional Trading of Fortrea

Several hedge funds and other institutional investors have recently bought and sold shares of FTRE. Hara Capital LLC acquired a new stake in shares of Fortrea during the 3rd quarter valued at approximately $29,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Fortrea in the fourth quarter worth $30,000. GF Fund Management CO. LTD. bought a new stake in Fortrea in the fourth quarter valued at $35,000. Covestor Ltd grew its position in shares of Fortrea by 102.4% during the third quarter. Covestor Ltd now owns 2,763 shares of the company’s stock worth $55,000 after acquiring an additional 1,398 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Fortrea by 21.4% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,241 shares of the company’s stock worth $64,000 after acquiring an additional 572 shares during the period.

About Fortrea

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.